Zai Lab (ZLAB) Receivables - Net (2018 - 2026)
Zai Lab (ZLAB) posted Receivables - Net of $54.1 million for Q1 2026, down 49.05% sequentially from $106.1 million in Q4 2025, and down 29.37% YoY from $76.6 million in Q1 2025.
Zai Lab (ZLAB) Receivables - Net (2018 - 2026) Analysis & Trends
Zai Lab has reported Receivables - Net for 9 years, with the latest figure at $54.1 million in Q1 2026.
- Quarterly Receivables - Net fell 29.37% year-over-year to $54.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.1 million (down 29.37% YoY) and the FY2025 annual result came in at $106.1 million, up 24.58% from the prior year.
- Receivables - Net fell to $54.1 million in Q1 2026 per ZLAB's latest filing, from $106.1 million in the prior quarter.
- Over five years, Receivables - Net peaked at $106.1 million in Q4 2025 and troughed at $7.8 million in Q4 2023.
- A 5-year average of $55.5 million and a median of $50.0 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net sank 80.48% in 2023, then jumped 992.03% in 2024.
- Over 5 years, Receivables - Net stood at $40.0 million in 2022, then tumbled by 80.48% to $7.8 million in 2023, then surged by 992.03% to $85.2 million in 2024, then advanced by 24.58% to $106.1 million in 2025, then plunged by 49.05% to $54.1 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $54.1 million, $106.1 million, and $85.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.60 Mn |
| Jun 30, 2026 | 69.60 Mn |
| Mar 31, 2026 | 54.07 Mn |
| Mar 31, 2026 | 54.07 Mn |
| Dec 31, 2025 | 106.12 Mn |
| Dec 31, 2025 | 106.12 Mn |
| Sep 30, 2025 | 85.38 Mn |
| Sep 30, 2025 | 85.38 Mn |
| Jun 30, 2025 | 88.50 Mn |
| Jun 30, 2025 | 88.50 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Sep 30, 2024 | 49.97 Mn |
| Sep 30, 2024 | 49.97 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Mar 31, 2024 | 60.42 Mn |
| Mar 31, 2024 | 60.42 Mn |